Pub. Date : 2021 Jun 7
PMID : 34099830
1 Functional Relationships(s)Download |
||||||
Sentence | Compound Name | Protein Name | Organism |
|||
| 1 | Recent studies suggested that ibrutinib, a Bruton tyrosine kinase (BTK) inhibitor, developed for the treatment of chronic lymphocytic leukemia, may prevent NLRP3 inflammasome activation in macrophages, IL-1beta secretion and subsequent development of inflammation and organ fibrosis. | ibrutinib | NLR family pyrin domain containing 3 | Homo sapiens | ||